Ronald Hunt insider trades
Open-market stock purchases and sales by Ronald Hunt, Director at Rallybio Corp, from SEC Form 4 filings since Jul 24, 2012.
Track record: 33% of 3 scored buys are up 5% or more since purchase, averaging -58%.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Feb 18, 2026 | RLYB Rallybio Corp | Bought (not open market) | $51.5K |
Companies traded
- RLYB Rallybio Corp: 1 buy, last Feb 18, 2026
- ITRM Iterum Therapeutics plc: 2 buys, last Jan 13, 2025
- HARP Harpoon Therapeutics, Inc: 7 buys, last Mar 11, 2024
- STIM Neuronetics, Inc: other filings, last Apr 1, 2019
- DRTX Durata Therapeutics, Inc: 1 buy, last May 21, 2014
- RLYP Relypsa Inc: 1 buy, last Nov 20, 2013